ArticleCancers2023

Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors.

Cristina Saavedra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.